Linoleate sodium - CAS 822-17-3

Linoleate sodium is an orally active regulator of IL8 mediated by JNK and NF-κB pathways. It can alter the composition of fatty acids and the production of metabolites within cells. Additionally, Linoleate sodium exhibits anti-inflammatory, immunomodulatory properties and influences tumor cell growth.

Interleukin, NF-κB, JNK

Immunology/Inflammation, NF-κB, MAPK

822-17-3

C18H31NaO2

302.4273

CCCCCC([H])=C(CC([H])=C(CCCCCCCC(O[Na])=O)[H])[H]

-20°C

Ice Packs

Inhibitors & Agonists